WHO vaccine-preventable diseases: monitoring system. 2014 global summary

Last updated 15-Jul-2014 (Data received as of 8-Jul-2014)
Next overall update Fall 2014
EPI mother and child logo         
Select a country

Development status: Least developed GNI / capita (US$): 4101 Infant (under 12 months) mortality rate: 562
GDP / capita (US$): 8781 Child (under 5 years) mortality rate: 752

Population data in thousands3

  2013  2012  2011  2010  2009  2000  1990  1980 
Total population 4'294  4'190  4'080  3'958  3'821  2'892  2'103  1'893 
Births 152  150  148  146  143  119  95  93 
Surviving infants 143  141  139  136  134  105  80  79 
Pop. less than 5 years 686  678  668  655  641  496  371  348 
Pop. less than 15 years 1'842  1'806  1'764  1'716  1'661  1'250  948  850 
Female 15-49 years 1'002  976  948  919  887  676  473  428 

Number of reported case

(Click for retrospective incidence data for Liberia)
Diphtheria
Japanese encephalitis
Measles 43  279  2'200  5'977  6'567 
Mumps
Pertussis 281  62 
Polio* 11  98 
Rubella 39  30 
Rubella (CRS)
Tetanus (neonatal) 12  152  207 
Tetanus (total) 12  228  307 
Yellow fever 17  137 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Liberia)
Vaccine year result method % card seen                                                
BCG 2011  94     77  87  85  85  76  92  45 
DTP1 2011  92     77  97  99*  86  85  100 
DTP3 2011  77     77  89  93  77  75  92  48 
HepB_BD         
HepB3 2011  77     77  89  93  77  75  93 
Hib3 2011  77     77  89  93  77  75  93 
JapEnc         
MCV 2011  62     77  74  80  71  72  95  52 
MCV2         
PCV1         
PCV3         
Pol3 2011  76     77  88  93  77  60  92  52 
Rota1         
Rota_last         
Rubella1         
TT2plus 1994  77  MICS     76  74  74  63  90  25 
PAB         
VAD1          58  43  56  63  73  26 
YFV 2011  61     77  73  78  70  71  95 
  ° indicates that more than 1 survey occurred that year

  Next update: July 2015

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Liberia)
BCG 87  85  85  73  87  78 
DTP1 97  97  86  80  90  80 
DTP3 89  93  77  70  81  46 
HepB3 89  93  77  47  64 
HepB_BD
Hib3 89  93  77  47  64 
MCV 74  80  71  65  83  63 
MCV2
PAB 91  91  91  91  91  51  33 
PCV3
Pol3 88  93  77  71  84  56 
Rota_last
YFV 73  78  70  64  83 

Number of districts in the country 15  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 53
From 80 to 89% 33
From 50 to 79% 13
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2013 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwPHibHepB 6, 10, 14 weeks; Yes
Measles 9 months; Yes
OPV birth; 6, 10, 14 weeks; Yes
Pneumo_conj 6, 10, 14 weeks; Yes From January 2014
TT 1st contact pregnancy; +1, +6 months; +1, +1 year; Yes
VitaminA 6, 12 months; Yes
YF 9 months; Yes

Immunizaton indicators

Indicator Expected answer 2013  2012  2011  2010  2009  2008  2007 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2011-2015  2011-2015  2011-2015  2011-2015  2006-2010  2006-2010  2006-2010 
Nº of districts with microplans that include activities to raise immunization coverage number 15  15  15  15  15  15 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes       

System performance

Total Nº districts in country number 15  15  15  15  15  15  15 
Nº districts with DTP3 coverage >=80% number 13  14  13  14 
% of districts with DTP3 coverage >=80% From 0 to 100% 87  93  53  47  87  93  20 
Nº districts with measles (MCV1) coverage >=95% number 10  12   
% of districts with MCV1 coverage >=95% From 0 to 100% 13  13  67  80   

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  No       
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  No    Yes  Yes 

Finance

Estimated percentage of routine vaccines funded by Government From 0 to 100% 91   

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.